⌘K

Home/Filings/4/0001683168-24-000705

4//SEC Filing

Climaco John M 4

Accession 0001683168-24-000705

CIK 0001729427other

View on SEC.gov Company Profile

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 10:27 AM ET

Size

9.2 KB

Accession

0001683168-24-000705

Insider Transaction Report

Form 4

Period: 2024-02-01

CNS Pharmaceuticals, Inc.CNSP

DirectorChief Executive Officer

Transactions

Award
Series B Warrant to purchase common stock
2024-02-01+166,666→ 393,533 total
Exercise: $0.30From: 2024-02-01Exp: 2025-10-01→ Common Stock (166,666 underlying)
Award
Series A Warrant to purchase common stock
2024-02-01+166,666→ 226,867 total
Exercise: $0.30From: 2024-02-01Exp: 2029-02-01→ Common Stock (166,666 underlying)
Purchase
Common stock
2024-02-01$0.30/sh+166,666$50,000→ 215,676 total

Footnotes (1)

[F1]The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.

Documents

1 file

4
ownership.xmlPrimary

Issuer

CNS Pharmaceuticals, Inc.

CIK 0001729427

Entity typeother

Related Parties

1

filerCIK 0001546797

Filing Metadata

Form type: 4
Filed: Feb 5, 7:00 PM ET
Accepted: Feb 6, 10:27 AM ET
Size: 9.2 KB

View on SEC.gov